Robinson, Philip C. http://orcid.org/0000-0002-3156-3418
Frampton, Christopher
Phipps-Green, Amanda
Neogi, Tuhina
Stamp, Lisa
Taylor, William http://orcid.org/0000-0001-6075-8479
Merriman, Tony R.
Dalbeth, Nicola
Article History
Received: 6 April 2021
Accepted: 21 May 2021
First Online: 28 August 2021
Declarations
:
: The study received ethical approval and all participants gave written informed consent.All methods were performed in accordance with the relevant guidelines and regulations. The component studies (ARIC, FHS, CARDIA) had separate IRB approvals, described at ExternalRef removed. This study was approved by the University of Otago Human Health Ethics Committee.
: Not applicable.
: Philip Robinson reports personal fees from Abbvie, Eli Lilly, Gilead, Janssen, Novartis, Pfizer Roche, UCB Pharma; grants from Janssen, Novartis, Pfizer and UCB and non-financial support from BMS all outside the submitted work; Christopher Frampton declares he has no competing interests; Amanda Phipps-Green declares she has no competing interests; Tuhina Neogi declares she has no competing interests, Lisa Stamp declares she has no competing interests, William Taylor declares he has no competing interests; Tony R. Merriman declares he has no competing interests and Nicola Dalbeth reports grants and personal fees from AstraZeneca, personal fees from Kowa, Horizon, Abbvie, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi, and grants from Amgen outside the submitted work.